224 related articles for article (PubMed ID: 15215878)
1. Endothelium and angiogenesis in white coat hypertension.
Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
[TBL] [Abstract][Full Text] [Related]
3. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
4. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
5. Circulating homocysteine levels in sustained and white coat hypertension.
Pierdomenico SD; Bucci A; Lapenna D; Lattanzio FM; Talone L; Cuccurullo F; Mezzetti A
J Hum Hypertens; 2003 Mar; 17(3):165-70. PubMed ID: 12624606
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in white coat hypertension; role of paraoxonase.
Uzun H; Karter Y; Aydin S; Curgunlu A; Simşek G; Yücel R; Vehiyd S; Ertürk N; Kutlu A; Benian A; Yaldiran A; Oztürk E; Erdine S
J Hum Hypertens; 2004 Jul; 18(7):523-8. PubMed ID: 14985779
[TBL] [Abstract][Full Text] [Related]
7. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
Głowińska B; Urban M; Peczyńska J; Florys B
Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction in patients with noncomplicated and complicated hypertension.
Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
Clin Exp Hypertens; 2009 Feb; 31(1):20-30. PubMed ID: 19172456
[TBL] [Abstract][Full Text] [Related]
9. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension.
Yildiz A; Gür M; Yilmaz R; Demirbağ R; Celik H; Aslan M; Koçyiğit A
Turk Kardiyol Dern Ars; 2008 Jun; 36(4):231-8. PubMed ID: 18765966
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure on arising, morning blood pressure surge and blood pressure variability in white coat hypertensives and in matched normotensives and sustained hypertensives.
Polónia J; Carvalho N; Barbosa L; Silva JA
Rev Port Cardiol; 2006; 25(7-8):693-704. PubMed ID: 17069435
[TBL] [Abstract][Full Text] [Related]
12. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
13. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension.
Pierdomenico SD; Lapenna D; Bucci A; Di Iorio A; Neri M; Cuccurullo F; Mezzetti A
Am J Hypertens; 2004 Oct; 17(10):876-81. PubMed ID: 15485748
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension.
Vyzantiadis T; Karagiannis A; Douma S; Harsoulis P; Vyzantiadis A; Zamboulis C
Clin Exp Hypertens; 2006 Oct; 28(7):603-9. PubMed ID: 17032626
[TBL] [Abstract][Full Text] [Related]
16. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
Curgunlu A; Karter Y; Uzun H; Aydin S; Ertürk N; Vehid S; Simsek G; Kutlu A; Oztürk E; Erdine S
Int Heart J; 2005 Mar; 46(2):245-54. PubMed ID: 15876808
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
Conen D; Dieterle T; Utech K; Rimner M; Martina B
Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
[TBL] [Abstract][Full Text] [Related]
19. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
[TBL] [Abstract][Full Text] [Related]
20. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure.
Cottone S; Mulè G; Amato F; Riccobene R; Vadalà A; Lorito MC; Raspanti F; Cerasola G
J Nephrol; 2002; 15(6):643-8. PubMed ID: 12495277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
